{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T13:13:55Z","timestamp":1782911635979,"version":"3.54.5"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ejphar.2022.174910","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T02:50:45Z","timestamp":1648003845000},"page":"174910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["A promising antifibrotic drug, pyridoxamine attenuates thioacetamide-induced liver fibrosis by combating oxidative stress, advanced glycation end products, and balancing matrix metalloproteinases"],"prefix":"10.1016","volume":"923","author":[{"given":"Aliah R.","family":"Alshanwani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Hagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameerah","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahlam M.","family":"Alhusaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha M.","family":"Arafah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila M.","family":"Faddah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima MB.","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel","family":"Fayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira M.","family":"Badr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2022.174910_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1302\/2046-3758.71.BJR-2017-0135.R1","article-title":"The effect of aminoguanidine (AG) and pyridoxamine (PM) on ageing human cortical bone","volume":"7","author":"Abar","year":"2018","journal-title":"Bone Joint Res."},{"key":"10.1016\/j.ejphar.2022.174910_bib2","article-title":"Preventive effect of salicylate and pyridoxamine on diabetic nephropathy","volume":"10","author":"Abouzed","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ejphar.2022.174910_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1021\/tx0300535","article-title":"Pyridoxamine: an extremely potent scavenger of 1,4-dicarbonyls","volume":"17","author":"Amarnath","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2022.174910_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.02014","article-title":"Interleukin-1 family cytokines: keystones in liver inflammatory diseases","volume":"10","author":"Barbier","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2022.174910_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086137","article-title":"Gene expression profiling and secretome analysis differentiate adult-derived human liver stem\/progenitor cells and human hepatic stellate cells","volume":"9","author":"Berardis","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2022.174910_bib6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0076-6879(78)52032-6","article-title":"Biomembranes - Part C: biological oxidations","volume":"52","author":"Buege","year":"1978","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejphar.2022.174910_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037917","article-title":"Induction of neuronal death by microglial AGE-albumin: implications for Alzheimer's disease","volume":"7","author":"Byun","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2022.174910_bib8","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.cgh.2017.12.048","article-title":"High prevalence of liver fibrosis among European adults with unknown liver disease: a population-based study","volume":"16","author":"Caballer\u00eda","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2022.174910_bib9","doi-asserted-by":"crossref","first-page":"29267","DOI":"10.1074\/jbc.M113.498832","article-title":"Pretreatment with pyridoxamine mitigates isolevuglandin associated retinal effects in mice exposed to bright light","volume":"288","author":"Charvet","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2022.174910_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2682861","article-title":"Protective effects of pyridoxamine supplementation in the early stages of diet-induced kidney dysfunction","author":"Chiazza","year":"2017","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejphar.2022.174910_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu9030189","article-title":"Pyridoxine (Vitamin B6) and the glutathione peroxidase system; a link between one-carbon metabolism and antioxidation","volume":"9","author":"Dalto","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2022.174910_bib12","first-page":"4320","article-title":"AGER1 downregulation associates with fibrosis in nonalcoholic steatohepatitis and type 2 diabetes","volume":"140","author":"Dehnad","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2022.174910_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-16255-y","article-title":"Pyridoxamine improves survival and limits cardiac dysfunction after MI","volume":"7","author":"Deluyker","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2022.174910_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cbi.2006.05.010","article-title":"Mitochondrial function and toxicity: role of B vitamins on the one-carbon transfer pathways","volume":"163","author":"Depeint","year":"2006","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2022.174910_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.matbio.2015.01.004","article-title":"Matrix metalloproteinases in liver injury, repair and fibrosis Sergio","volume":"176","author":"Duarte","year":"2015","journal-title":"Matrix Biol"},{"key":"10.1016\/j.ejphar.2022.174910_bib16","first-page":"70","volume":"82","author":"Ellman","year":"1959","journal-title":"Tissue Sulfhydryl Groups"},{"key":"10.1016\/j.ejphar.2022.174910_bib17","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1177\/1535370213494644","article-title":"Pyridoxamine, an inhibitor of protein glycation, in relation to microalbuminuria and proinflammatory cytokines in experimental diabetic nephropathy","volume":"238","author":"Elseweidy","year":"2013","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ejphar.2022.174910_bib18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3350\/cmh.2017.0019","article-title":"Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals","volume":"23","author":"Ferro","year":"2017","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.ejphar.2022.174910_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20205037","article-title":"Development and progression of non-alcoholic fatty liver disease: the role of advanced glycation end products","volume":"20","author":"Fernando","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2022.174910_bib21","first-page":"9","article-title":"Matrix metalloproteinases as potential biomarkers and therapeutic targets in liver diseases","author":"Geervliet","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2022.174910_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2036.2004.02115.x","article-title":"Review article: pharmacological treatment of hepatorenal syndrome","volume":"20","author":"Gin\u00e8s","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2022.174910_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/0001-3765201920190434","article-title":"Vitamin B6 reduces oxidative stress in lungs and liver in experimental sepsis","volume":"91","author":"Giustina","year":"2019","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/j.ejphar.2022.174910_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20246302","article-title":"A novel hepatic anti-fibrotic strategy utilizing the secretome released from etanercept-synthesizing adipose-derived stem cells","volume":"20","author":"Han","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2022.174910_bib25","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","article-title":"Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies","volume":"46","author":"Hemmann","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2022.174910_bib26","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2022.174910_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.molmet.2019.08.003","article-title":"Cognitive dysfunction in diabetic rats is prevented by pyridoxamine treatment. A multidisciplinary investigation","volume":"28","author":"Kassab","year":"2019","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.ejphar.2022.174910_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/bbrc.1999.0371","article-title":"Breakthroughs and views. Amadorins: novel post-Amadori inhibitors of advanced glycation reactions","volume":"257","author":"Khalifah","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2022.174910_bib29","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep4.1150","article-title":"Role of monocyte chemoattractant protein\u20101 in liver fibrosis with transient myeloproliferative disorder in down syndrome","volume":"2","author":"Kobayashi","year":"2018","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ejphar.2022.174910_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3164\/jcbn.20-142","article-title":"Vitamin B6 efficacy in the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, single-center trial","volume":"68","author":"Kobayashi","year":"2021","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.ejphar.2022.174910_bib31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S1499-3872(14)60261-7","article-title":"Role of MMP-2 and MMP-9 and their natural inhibitors in liver fibrosis, chronic pancreatitis and non-specific inflammatory bowel diseases","volume":"13","author":"Kurzepa","year":"2014","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.ejphar.2022.174910_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1748065","article-title":"Vitamin B6 prevents endothelial dysfunction, insulin resistance, and hepatic lipid accumulation in Apoe (\u2013\/\u2013) mice fed with high-fat diet","volume":"2016","author":"Liu","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ejphar.2022.174910_bib34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2022.174910_bib35","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/db15-1390","article-title":"Delayed intervention with pyridoxamine improves metabolic function and prevents adipose tissue inflammation and insulin resistance in high-fat diet-induced obese mice","volume":"65","author":"Maessen","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2022.174910_bib36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/jomfp.JOMFP_234_16","article-title":"Validation of immunoexpression of tenascin-C in oral precancerous and cancerous tissues using ImageJ analysis with novel immunohistochemistry profiler plugin: an immunohistochemical quantitative analysis","volume":"21","author":"Mane","year":"2017","journal-title":"J. Oral Maxillofac. Pathol."},{"key":"10.1016\/j.ejphar.2022.174910_bib37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-pharmtox-031620-035348","article-title":"Scavenging reactive lipids to prevent oxidative injury","volume":"61","author":"May-Zhang","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2022.174910_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20061295","article-title":"Interleukin-1 receptor antagonist modulates liver inflammation and fibrosis in mice in a model-dependent Manner","volume":"20","author":"Meier","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2022.174910_bib39","first-page":"1","article-title":"Contemporary epidemiology of chronic liver disease and cirrhosis","author":"Moon","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2022.174910_bib40","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2353\/ajpath.2007.060456","article-title":"Fibronectin-\u03b14\u03b21 integrin interactions regulate metalloproteinase-9 expression in steatotic liver ischemia and reperfusion injury","volume":"170","author":"Moore","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2022.174910_bib41","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3748\/wjg.v12.i19.3044","article-title":"Correlation between TIMP-1 expression and liver fibrosis in two rat liver fibrosis models","volume":"12","author":"Nie","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2022.174910_bib42","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/biom5010194","article-title":"Advanced glycation end products and oxidative stress in type 2 diabetes mellitus","volume":"5","author":"Nowotny","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejphar.2022.174910_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2019.04.001","article-title":"The attenuating effects of pyridoxamine on adipocyte hypertrophy and inflammation differ by adipocyte location","volume":"72","author":"Oh","year":"2019","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.ejphar.2022.174910_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/micc.12603","article-title":"Pyridoxamine improves metabolic and microcirculatory complications associated with nonalcoholic fatty liver disease","volume":"27","author":"Pereira","year":"2020","journal-title":"Microcirculation"},{"key":"10.1016\/j.ejphar.2022.174910_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/antiox8090344","article-title":"How does pyridoxamine inhibit the formation of advanced glycation end products? The role of its primary antioxidant activity","volume":"8","author":"Ramis","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2022.174910_bib46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Ram\u00f3n","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2022.174910_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/690650","article-title":"Reduction of methylglyoxal-induced glycation by pyridoxamine improves adipose tissue microvascular lesions","author":"Rodrigues","year":"2013","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ejphar.2022.174910_bib48","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.matbio.2017.12.012","article-title":"Matrix metalloproteinases and liver fibrosis (translational aspects)","volume":"68\u201369","author":"Roeb","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ejphar.2022.174910_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.fct.2018.02.017","article-title":"Detoxifying effect of pyridoxine on acetaminophen-induced hepatotoxicity via suppressing oxidative stress injury","volume":"114","author":"Roh","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejphar.2022.174910_bib50","doi-asserted-by":"crossref","first-page":"F268","DOI":"10.1152\/ajprenal.00056.2016","article-title":"Pyridoxamine reduces postinjury fibrosis and improves functional recovery after acute kidney injury","volume":"311","author":"Skrypnyk","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2022.174910_bib51","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.2147\/DMSO.S211253","article-title":"High-fat diet-induced kidney alterations in rats with metabolic syndrome: endothelial dysfunction and decreased antioxidant defense","volume":"12","author":"Silvares","year":"2019","journal-title":"Diabetes, Metab. Syndrome Obes. Targets Ther."},{"key":"10.1016\/j.ejphar.2022.174910_bib52","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.metabol.2006.08.026","article-title":"Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-Ay\/Ta mice","volume":"56","author":"Tanimoto","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2022.174910_bib53","series-title":"Redox- and Non-redox-metal-induced Formation of Free Radicals and Their Role in Human Disease, Archives of Toxicology","author":"Valko","year":"2016"},{"key":"10.1016\/j.ejphar.2022.174910_bib54","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/path.1594","article-title":"Increased expression of matrix metalloproteinases in the murine zymosan-induced multiple organ dysfunction syndrome","volume":"203","author":"Volman","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejphar.2022.174910_bib55","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Vos","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2022.174910_bib57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/0023677215573040","article-title":"Standard operating procedures in experimental liver research: thioacetamide model in mice and rats","volume":"49","author":"Wallace","year":"2015","journal-title":"Lab. Anim."},{"key":"10.1016\/j.ejphar.2022.174910_bib58","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1113\/expphysiol.2014.082008","article-title":"Pyridoxamine protects against mechanical defects in cardiac ageing in rats: studies on load dependence of myocardial relaxation","volume":"99","author":"Wang","year":"2014","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.ejphar.2022.174910_bib59","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.etap.2010.05.005","article-title":"Pyridoxine mitigates cadmium induced hepatic cytotoxicity and oxidative stress","volume":"30","author":"Wen","year":"2010","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.174910_bib60","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1159\/000108104","article-title":"Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy","volume":"27","author":"Williams","year":"2007","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.ejphar.2022.174910_bib61","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.tips.2015.05.001","article-title":"Nitric oxide IN liver diseases","volume":"36","author":"Yasuko","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2022.174910_bib62","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1053\/jhep.2000.20521","article-title":"Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model","volume":"32","author":"Yoshiji","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2022.174910_bib63","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/jhep.2002.35625","article-title":"Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse","volume":"36","author":"Yoshiji","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2022.174910_bib64","first-page":"1","article-title":"Emodin alleviates liver fibrosis of mice by reducing infiltration of Gr1 hi monocytes","author":"Zhao","year":"2018","journal-title":"Evid. Compl. Altern. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922001716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922001716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:02:39Z","timestamp":1757977359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299922001716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":61,"alternative-id":["S0014299922001716"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.174910","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A promising antifibrotic drug, pyridoxamine attenuates thioacetamide-induced liver fibrosis by combating oxidative stress, advanced glycation end products, and balancing matrix metalloproteinases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.174910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"174910"}}